Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Journal of Hepato-Biliary-Pancreatic Surgery
|
April 1, 2009
Multi-centric pancreatic cancer without PanIN lesion
Yoshiki Naito, Naofumi Eriguchi, Tohru Kume, et al.
Plos Pathogens
|
February 15, 2013
Human monoclonal antibodies broadly neutralizing against influenza B virus
Mayo Yasugi, Ritsuko Kubota-Koketsu, Akifumi Yamashita, et al.
Biologics : Targets & Therapy
|
August 29, 2013
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
Chonlatip Pipattanaboon, Tadahiro Sasaki, Mitsuhiro Nishimura, et al.
Open Forum Infectious Diseases
|
October 11, 2021
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan
Koichi Furukawa, Lidya Handayani Tjan, Silvia Sutandhio, et al.
The Journal of Infectious Diseases
|
May 5, 2022
Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination
Yukiya Kurahashi, Koichi Furukawa, Silvia Sutandhio, et al.
Frontiers in Immunology
|
March 14, 2022
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections
Yukiya Kurahashi, Silvia Sutandhio, Koichi Furukawa, et al.
Plos One
|
April 5, 2022
Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak
Zhenxiao Ren, Mitsuhiro Nishimura, Lidya Handayani Tjan, et al.
Scientific Reports
|
March 23, 2022
Synthesis and assessment of copper-based nanoparticles as a surface coating agent for antiviral properties against SARS-CoV-2
Agung Purniawan, Maria Inge Lusida, Royan Wafi Pujiyanto, et al.
Plos Pathogens
|
July 24, 2020
Tetrameric glycoprotein complex gH/gL/gQ1/gQ2 is a promising vaccine candidate for human herpesvirus 6B
Bochao Wang, Kouichi Hara, Akiko Kawabata, et al.
Antiviral Research
|
April 3, 2013
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection
Tadahiro Sasaki, Chayanee Setthapramote, Takeshi Kurosu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Journal of Hepato-Biliary-Pancreatic Surgery
|
April 1, 2009
Multi-centric pancreatic cancer without PanIN lesion
Yoshiki Naito, Naofumi Eriguchi, Tohru Kume, et al.
Plos Pathogens
|
February 15, 2013
Human monoclonal antibodies broadly neutralizing against influenza B virus
Mayo Yasugi, Ritsuko Kubota-Koketsu, Akifumi Yamashita, et al.
Biologics : Targets & Therapy
|
August 29, 2013
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
Chonlatip Pipattanaboon, Tadahiro Sasaki, Mitsuhiro Nishimura, et al.
Open Forum Infectious Diseases
|
October 11, 2021
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan
Koichi Furukawa, Lidya Handayani Tjan, Silvia Sutandhio, et al.
The Journal of Infectious Diseases
|
May 5, 2022
Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination
Yukiya Kurahashi, Koichi Furukawa, Silvia Sutandhio, et al.
Frontiers in Immunology
|
March 14, 2022
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections
Yukiya Kurahashi, Silvia Sutandhio, Koichi Furukawa, et al.
Plos One
|
April 5, 2022
Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak
Zhenxiao Ren, Mitsuhiro Nishimura, Lidya Handayani Tjan, et al.
Scientific Reports
|
March 23, 2022
Synthesis and assessment of copper-based nanoparticles as a surface coating agent for antiviral properties against SARS-CoV-2
Agung Purniawan, Maria Inge Lusida, Royan Wafi Pujiyanto, et al.
Plos Pathogens
|
July 24, 2020
Tetrameric glycoprotein complex gH/gL/gQ1/gQ2 is a promising vaccine candidate for human herpesvirus 6B
Bochao Wang, Kouichi Hara, Akiko Kawabata, et al.
Antiviral Research
|
April 3, 2013
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection
Tadahiro Sasaki, Chayanee Setthapramote, Takeshi Kurosu, et al.
Page
of 6